A man was killed Saturday afternoon when his motorcycle collided with another vehicle on U.S. 98 in the Bellevue community.

Full Year 2024 Results Key Financial Results Revenue: US$179.3m (up 55% from ...

SOUTH SAN FRANCISCO, Calif., March 10, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that ...

Rigel Therapeutics expands oncology portfolio with REZLIDHIA & GAVRETO, sees promising R289 results. Click here to read my ...

Reports Q4 revenue $57.6M, consensus $57.59M. “2024 was a year of significant accomplishments for Rigel. We continued to focus on commercial ...

These increases were partially offset by decreased research and development costs due to the timing of clinical trial activities related to R289, Rigel's dual IRAK 1/4 inhibitor program ...

Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET. Company Participants. Ray Furey - Executive Vice President, General Counsel & ...

Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ) shareholders are probably feeling a little disappointed, since its ...

NasdaqGS:RIGL Earnings and Revenue History March 15th 2025 Zooming In On Rigel Pharmaceuticals' Earnings. One key financial ratio used to measure how well a company converts its p ...